NCT04642937 2023-01-27Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent GlioblastomaOX2 TherapeuticsPhase 1 Unknown24 enrolled
NCT00805636 2010-05-12Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.Aposense Ltd.Phase 2 Unknown30 enrolled